
OPKO Health OPK
$ 1.2
0.84%
Quarterly report 2025-Q2
added 07-31-2025
OPKO Health EV - Enterprise Value 2011-2026 | OPK
Annual EV - Enterprise Value OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.62 B | 1.27 B | 1.27 B | 2.61 B | 4.2 B | 1.49 B | 2.67 B | 3.17 B | 4.76 B | 4.65 B | 5.41 B | 3.23 B | 1.97 B | 1.46 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.41 B | 1.27 B | 2.84 B |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anixa Biosciences
ANIX
|
990 K | $ 2.96 | 4.59 % | $ 96.1 K | ||
|
Agilent Technologies
A
|
45.8 B | $ 120.72 | 1.45 % | $ 36.7 B | ||
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 22.3 | -5.27 % | $ 234 M | ||
|
Celcuity
CELC
|
506 M | $ 111.84 | 4.13 % | $ 4.41 B | ||
|
Castle Biosciences
CSTL
|
665 M | $ 28.19 | 2.25 % | $ 783 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 14.04 | 1.81 % | $ 424 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 180.3 | 2.54 % | $ 8.94 B | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
IDEXX Laboratories
IDXX
|
52.7 B | $ 649.32 | 2.17 % | $ 52.2 B | ||
|
Illumina
ILMN
|
15.3 B | $ 129.66 | 0.07 % | $ 20.6 B | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 281.13 | -0.68 % | $ 23.4 B | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 77.83 | -1.27 % | $ 5.25 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
142 M | $ 15.04 | -2.97 % | $ 1.95 B | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 294.19 | -1.66 % | $ 26.7 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 5.34 | 0.85 % | $ 494 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
NeoGenomics
NEO
|
1.85 B | $ 9.16 | -3.93 % | $ 1.17 B | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
National Research Corporation
NRC
|
1.08 B | $ 13.23 | -1.19 % | $ 325 M | ||
|
BioNano Genomics
BNGO
|
35.7 M | $ 1.16 | 3.12 % | $ 1.47 M | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 208.81 | 0.22 % | $ 23.2 B | ||
|
Danaher Corporation
DHR
|
145 B | $ 204.82 | 0.38 % | $ 146 B | ||
|
Organovo Holdings
ONVO
|
-4.05 M | - | -2.3 % | $ 19.4 M | ||
|
Exact Sciences Corporation
EXAS
|
22 B | $ 103.52 | 0.14 % | $ 19.5 B | ||
|
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.59 | 4.28 % | $ 477 M | ||
|
Bioventus
BVS
|
904 M | $ 8.5 | -2.75 % | $ 533 M | ||
|
DarioHealth Corp.
DRIO
|
6.61 M | $ 10.0 | -2.91 % | $ 284 M | ||
|
DexCom
DXCM
|
28.2 B | $ 73.02 | -0.08 % | $ 28.5 B | ||
|
PerkinElmer
PKI
|
4 B | - | -0.91 % | $ 14.7 B | ||
|
Psychemedics Corporation
PMD
|
20.5 M | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
10.9 M | $ 26.96 | 7.95 % | $ 35 M | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Personalis
PSNL
|
229 M | $ 8.86 | 2.13 % | $ 525 M | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 110.12 | 1.31 % | $ 9.08 B | ||
|
Quotient Limited
QTNT
|
393 M | - | -11.32 % | $ 1.1 M | ||
|
Renalytix AI plc
RNLX
|
33.9 M | - | 5.66 % | $ 22.7 M | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 19.23 | 2.29 % | $ 1.02 B |